Handouts are online – View handouts.pdf
Published: 06/03/2013
Reymundo Lozano, M.D., Ph.D. Dr. Lozano is a Pediatric Geneticist, who has dedicated his research to better understanding the molecular basis of genetic disorders associated with intellectual disabilities and autism spectrum disorders (ASD). He is an International Medical Graduate from Mexico and completed his subspecialty studies at UCLA. He specializes in the treatment of neurodevelopmental genetic syndromes including fragile X syndrome (FXS), Angelman syndrome, 15q duplication syndrome, 22q11 microdeletion syndrome, and Noonan syndrome and other RASopathies. His work focuses on different clinical trials for ASD and FXS. Dr. Lozano is dedicated to finding better treatments and eventually the cure for neurodevelopmental disorders. He is also studying the phenotypic variability of fragile X premutation carries and the additive effects of other “genetic hits” and environmental exposures. He pursues the genetic diagnosis of ASD, using cutting edge technology, including microarrays, mitochondrial function, and whole exome sequencing. Dr. Lozano is an advocate for minority participation in clinical trials and his goal is to provide the necessary information to enhance enrollment and retention of minority participants. He is involved in identifying the linguistic and systemic barriers to early diagnosis and intervention commonly found in Hispanic children with ID and ASD. He is also interested in increasing diversity among medical students and faculty members at UC Davis.
Prenatal exposure to cannabis may increase likelihood of autism
Cannabis use during pregnancy may alter placental and fetal DNA methylation (the process of turning genes “on” and “off”) in ways that increase the likelihood of autism spectrum disorder (ASD) or other
New multi-national study adds to evidence linking alterations of the gut microbiome to autism
Strong new evidence linking alterations of the gut microbiome to autism spectrum disorders (ASD) comes from a new multi-national study by James Morton and colleagues. In the study, researchers in North America,
Sleep problems in infancy associated with ASD, autism traits, and social attention alterations
A new study from the United Kingdom indicates that sleep problems in infancy may help to predict later social skills deficits, autism traits, and autism diagnoses in children. Jannath Begum-Ali and colleagues
Preemptive therapy prior to autism diagnosis may be highly cost-effective
Preemptive therapy for infants who display early symptoms of autism may be highly cost-effective, according to a new study from Australia. Leonie Segal and colleagues based their economic analysis on a 2021
Earlier intervention leads to greater benefits for kids with autism
Children with autism spectrum disorders (ASD) who receive intensive early intervention at the age of 18 months fare significantly better than those who begin receiving this type of intervention at 27 months
ARI: Advancing our Understanding of Autism
Established in 1967, the Autism Research Institute (ARI) is the world's longest-standing organization dedicated to autism research. For more than half a century, we’ve worked to improve the quality of life for